CCR-3 receptor antagonists

Details for Australian Patent Application No. 2004215679 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Gong, Leyi

Agent Davies Collison Cave

Pub. Number AU-A-2004215679

PCT Pub. Number WO2004/076448

Priority 60/450,380 27.02.03 US

Filing date 19 February 2004

Wipo publication date 10 September 2004

International Classifications

C07D 451/02 Heterocyclic compounds containing condensed hetero ring systems

C07D 453/06 Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

A61K 031/4748 - forming part of bridged ring systems

A61K 031/46 - 8-Azabicyclo [3.2.1] octane

Event Publications

15 September 2005 PCT application entered the National Phase

  PCT publication WO2004/076448 Priority application(s): WO2004/076448

21 February 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004215680-Accelerator admixture

2004215678-Cycloalkyl-substituted alkanoic acid derivatives, methods for the production thereof, and use thereof as a medicament